Holen Sie sich die Stockscreener-App
1.68
6.15%
-0.11
Handel nachbörslich:
1.65
-0.03
-1.79%
Schlusskurs vom Vortag:
$1.79
Offen:
$1.8
24-Stunden-Volumen:
160.68K
Relative Volume:
0.13
Marktkapitalisierung:
$20.49M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-15.15%
1M Leistung:
-36.84%
6M Leistung:
-36.84%
1J Leistung:
-95.32%
1-Tages-Spanne:
$1.64
$1.8399
1-Wochen-Bereich:
$1.5685
$2.0799
52-Wochen-Spanne:
$1.345
$53.79
Q 32 Bio Inc Stock (QTTB) Company Profile
Firmenname
Q 32 Bio Inc
Sektor
Branche
Telefon
781-999-0232
Adresse
830 WINTER STREET, WALTHAM
Vergleichen Sie QTTB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
1.68 | 21.83M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-11 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-12-11 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-24 | Eingeleitet | Raymond James | Strong Buy |
| 2024-09-11 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-17 | Eingeleitet | Guggenheim | Buy |
| 2024-05-21 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-02 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | Bestätigt | BTIG Research | Neutral |
| 2022-02-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-02-22 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-12-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-03-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-02-24 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-11-01 | Eingeleitet | Oppenheimer | Perform |
| 2019-09-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-04-12 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Q 32 Bio Inc Aktie (QTTB) Neueste Nachrichten
Is Q32 Bio Inc. stock bottoming outStock Price Prediction Using AI Tools - Newser
Should you wait for a breakout in Q32 Bio Inc.Free Triple Return Setup with Risk Control - Newser
Long term hold vs stop loss in Q32 Bio Inc.Free News Based Entry Opportunity Alerts - Newser
Q32 Bio Inc. stock outlook for YEARMarket Ready Picks with Technical Support - Newser
Does Q32 Bio Inc. qualify in momentum factor screeningFree AI Screening for Swing Trade Picks - Newser
Can a trend reversal in Q32 Bio Inc. lead to recoveryFree Trade Scanner With Buy Zone Alerts - Newser
Can trapped investors hope for a rebound in Q32 Bio Inc.Smart Risk Entry Zone Technical Analysis - Newser
Published on: 2025-08-11 00:13:26 - Newser
Using portfolio simulators with Q32 Bio Inc. includedMarket Stability and Long-Term Growth Outlook - Newser
How to use Fibonacci retracement on Q32 Bio Inc.Daily Market Momentum and Pressure Analysis - Newser
Using data tools to time your Q32 Bio Inc. exitBuy Strategy Tracker with Growth Indicators - Newser
How Q32 Bio Inc. stock reacts to Fed policy changesSwing Trade Entry and Exit Point Analysis - Newser
Will Q32 Bio Inc. benefit from rate cutsTop Fast Growth Opportunities - thegnnews.com
Will Q32 Bio Inc. rebound enough to break evenReal-Time AI Generated Market Forecast - Newser
Understanding Q32 Bio Inc.’s price movementTrend Reversal Watch with Entry Signals - Newser
What earnings revisions data tells us about Q32 Bio Inc.Free High Yield Stock Screening Results - Newser
Historical volatility pattern of Q32 Bio Inc. visualizedVolume Based Swing Signal Prediction Map - Newser
Q32 Bio Inc. Reports Continued Losses Amid Development Efforts - TipRanks
Q32 Bio (QTTB) Expected to Announce Quarterly Earnings on Thursday - Defense World
Q32 Bio August 2025 slides: Bempikibart shows durable response in alopecia areata - Investing.com
Q32 Bio: Q2 Earnings Snapshot - The Washington Post
Q32 Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Q32 Bio Inc. SEC 10-Q Report - TradingView
Q32 Bio Secures FDA Fast Track for Alopecia Treatment as Phase 2 Trial Advances with $54.8M Runway - Stock Titan
Intrinsic Value of Q32 Bio Inc. Stock: Is It Undervalued or OvervaluedDaily Pick Forecast with Entry Zones - Newser
Q32 Bio Inc expected to post a loss of 98 cents a shareEarnings Preview - TradingView
Resistance Break Could Fuel Q32 Bio Inc. RallyNews Based Entry Opportunity Alerts Detected - metal.it
Finanzdaten der Q 32 Bio Inc-Aktie (QTTB)
Es liegen keine Finanzdaten für Q 32 Bio Inc (QTTB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.91%
3.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):